Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
912.92
+1.33 (0.15%)
At close: Jun 2, 2025
34.16%
Market Cap 48.30B
Revenue (ttm) 25.51B
Net Income (ttm) 3.53B
Shares Out 52.98M
EPS (ttm) 66.70
PE Ratio 13.67
Forward PE n/a
Dividend 40.00 (4.39%)
Ex-Dividend Date Apr 18, 2025
Volume 6,674
Average Volume 22,705
Open 915.00
Previous Close 911.59
Day's Range 906.00 - 920.00
52-Week Range 626.96 - 1,000.00
Beta 0.12
RSI 50.96
Earnings Date May 12, 2025

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, an... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,376
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2024, Highnoon Laboratories's revenue was 24.63 billion, an increase of 24.60% compared to the previous year's 19.77 billion. Earnings were 3.39 billion, an increase of 38.44%.

Financial Statements

News

There is no news available yet.